![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7441788 / 38401-38606
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T126 | 64-69 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T22 | 64-69 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T153 | 64-77 | Disease | denotes | heart disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T280 | 64-69 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | heart |
T281 | 64-69 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | heart |
T282 | 64-69 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | heart |
T283 | 64-69 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | heart |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T393 | 0-2 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T394 | 117-122 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T395 | 147-152 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T396 | 154-168 | Chemical | denotes | antihistamines | http://purl.obolibrary.org/obo/CHEBI_37956 |
T397 | 174-186 | Chemical | denotes | moxifloxacin | http://purl.obolibrary.org/obo/CHEBI_63611 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T229 | 0-2 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T230 | 174-186 | Chemical | denotes | moxifloxacin | http://purl.obolibrary.org/obo/CHEBI_63611 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T261 | 0-205 | Sentence | denotes | CQ/HCQ should be more cautiously used in patients with existing heart disease, and the use of QT interval prolonging drugs, such as antiarrhythmic drugs, antihistamines, and moxifloxacin should be avoided. |
LitCovid-sample-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T20 | 64-69 | Body_part | denotes | heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
1352 | 41-49 | Species | denotes | patients | Tax:9606 |
1387 | 0-6 | Chemical | denotes | CQ/HCQ | |
1388 | 174-186 | Chemical | denotes | moxifloxacin | MESH:D000077266 |
1417 | 64-77 | Disease | denotes | heart disease | MESH:D006331 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T145 | 70-77 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-FMA
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T125 | 64-69 | Body_part | denotes | heart | http://purl.org/sig/ont/fma/fma7088 |
LitCovid-sample-PD-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T19 | 64-69 | http://purl.obolibrary.org/obo/MAT_0000036 | denotes | heart |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T146 | 64-77 | Disease | denotes | heart disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1352 | 41-49 | Species | denotes | patients | Tax:9606 |
1387 | 0-6 | Chemical | denotes | CQ/HCQ | |
1388 | 174-186 | Chemical | denotes | moxifloxacin | MESH:D000077266 |
1417 | 64-77 | Disease | denotes | heart disease | MESH:D006331 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T261 | 0-205 | Sentence | denotes | CQ/HCQ should be more cautiously used in patients with existing heart disease, and the use of QT interval prolonging drugs, such as antiarrhythmic drugs, antihistamines, and moxifloxacin should be avoided. |